Connect with us

National

EU to further study blood clot cases linked to AstraZeneca’s COVID-19 vaccine – Financial Post

Europe’s drugs regulator said on Thursday its safety panel will call a meeting of experts on March 29 to further study the reported cases of blood clots linked…

Published

on

Europes drugs regulator said on Thursday its safety panel will call a meeting of experts on March 29 to further study the reported cases of blood clots linked to the COVID-19 vaccine developed by AstraZeneca and Oxford University.
External medical experts and two public representatives are expected to give their views on possible reasons for the clots, how they are occurring and other possible risks, the European Medicines Agency said https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-update-ongoing-evaluation-blood-clot-cases.

Click here to view the original article.